Secondary analysis of a trial in 89 patients with severe alcohol-associated hepatitis (anakinra regimen vs methylprednisolone): cytokines changed over time and improved in survivors but mostly had not normalised by day 180; markers of 90-day mortality differed by treatment.
Secondary analysisn = 89
Tornai et al. Longitudinal assessment of the circulating cytokine profile of severe alcohol-associated hepatitis